Cytologic, immunologic, and clinical diversity in non-Hodgkin's lymphoma: therapeutic implications.
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000166:cytology / Q000276:immunology; D002454:Cell Differentiation; D002869:Chromosome Aberrations / Q000276:immunology; D025063:Chromosome Disorders; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D008223:Lymphoma / Q000145:classification / Q000188:drug therapy / Q000276:immunology / Q000473:pathology* / Q000532:radiotherapy; D010641:Phenotype; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D007143:Immunoglobulin Heavy Chains